DDR2/STAT3正反循环通过调节PD-L1和招募oxaliplatin耐药HCC中的MDSC来调解免疫抑制的微环境

Wenfeng Liu1, Feng Zhang2, Bing Quan2

  • 1Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China; National Clinical Research Center for Interventional Medicine, Shanghai, China; Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.

概括

一个DDR2和STAT3的反循环通过促进免疫逃逸,驱动肝癌中牛氧的耐药性. 针对这种途径可以克服肝细胞癌 (HCC) 中的化学抵抗和免疫逃逸.